宠物肥胖管理市场：依年龄层、产品及通路－2026-2032年全球预测

预计到 2025 年，宠物肥胖管理市场价值将达到 98.7 亿美元，到 2026 年将成长至 105.3 亿美元，到 2032 年将达到 174.5 亿美元，复合年增长率为 8.47%。

主要市场统计数据
基准年 2025	98.7亿美元
预计年份：2026年	105.3亿美元
预测年份 2032	174.5亿美元
复合年增长率 (%)	8.47%

全面介绍宠物肥胖管理：系统化市场动态、相关人员优先事项以及塑造未来策略的新兴驱动因素。

宠物肥胖管理已从边缘的福利问题转变为伴侣动物预防保健策略的核心支柱。兽医界对肥胖作为慢性疾病诱发因素的认识不断提高，加上宠物饲养量的增加和动物拟人化趋势，推动了对涵盖诊断、营养、行为矫正和监测技术的综合干预措施的需求。包括兽医从业人员、专业製造商、零售商和宠物护理服务机构在内的利益相关者，正在重新评估与体重相关的健康问题，并将其列为优先事项，同时兼顾饲主对便利性、成本效益和人道关怀的相关人员。

对宠物肥胖管理的变革性转变进行分析，包括新技术的采用、消费行为以及兽医和零售通路不断变化的角色。

过去几年，变革性的改变从根本上重新定义了我们预防、诊断和管理宠物肥胖的方式。穿戴式活动监测器和智慧餵食器的进步带来了持续的行为数据，从而实现了个人化规划和远端监测。零售和兽医服务模式的同步变革，例如订阅服务和远端医疗咨询，提高了为期数月的体重管理专案的可及性和连续性。这些技术和服务创新得益于一种将宠物视为家庭成员的文化趋势，这种趋势提高了饲主在预防和长期照护方面的投入意愿。

评估美国在 2025 年征收的关税对宠物肥胖管理供应链、采购成本和跨境产品贸易的累积影响。

美国2025年实施的扩大关税措施对宠物肥胖管理生态系统中的供应商、製造商、经销商和终端用户产生了连锁反应。进口原料、监测设备专用组件以及某些成品营养品的关税提高了到岸成本，并改变了采购标准。为此，采购部门开始采取供应商多元化、近岸外包和成本转嫁等策略，这些策略正在影响产品定价、促销策略和分销管道的经济效益。对于那些依赖高精度感测器或国内替代品有限的专有组件的公司而言，这些变化尤其显着。

透过按年龄层、动物种类、产品类型和分销管道进行细分而获得的策略见解，可为有针对性的产品和服务规划提供指南。

为了更细緻地了解产品性能，必须考虑年龄、物种、产品类型和通路如何相互作用，从而影响需求和结果。年龄层会影响发病率和治疗方案：成年动物需要持续的维护策略，幼猫和幼犬受益于早期营养干预和行为训练，而老年动物则需要量身定制的处方和监测来控制合併症。动物物种也至关重要。猫和狗的代谢特征和行为模式各不相同，即使在这些群体内部也存在进一步的异质性。猫通常按品种类型分类，例如家养短毛猫或纯种猫，这可能与它们的活动水平和代谢倾向有关。狗通常按体型大小进行评估，大型、中型和小型犬的分类会影响其卡路里需求、运动处方和产品用量。

影响产品开发、分销和政策应对的区域趋势，以及美洲、欧洲、中东和非洲以及亚太地区的比较分析。

区域趋势对产品设计、分销策略、法规遵循和消费者期望都有显着影响。在美洲，成熟的兽医通路和宠物人性化趋势推动了对经临床检验的解决方案、订阅服务和高端营养产品的需求。该地区的消费者通常期望获得营养管理、监控和专家支援的一体化服务，而经销商，以建立转诊途径和合规计画。

概述竞争格局，重点介绍主要企业。

宠物肥胖管理领域的竞争优势归根究底在于能否将临床可信度、可扩展的经销网络和差异化的客户体验完美结合。主要企业正透过多元化的研发投入、与兽医网路的合作以及试点计画来应对这项挑战，以在真实环境中检验综合解决方案。通用的策略重点包括：为产品声明建立循证基础、开发可互通的设备和数据平台，以及创建鼓励长期持续使用的服务模式。一些机构强调以优质的营养科学和临床试验数据来支持兽医的建议，而其他机构则专注于数位互动和订阅经济模式，以实现可持续的收入成长。

为行业领导者提供切实可行的建议，以利用成长机会、降低贸易波动风险并加快负责任的肥胖管理计划。

产业领导者应采取实际行动，兼顾临床可信度和商业性扩充性。首先，应优先进行临床研究和真实世界结果监测，以产生证据，从而支持产品声明并强化兽医的建议。其次，应开发可互通的数位化平台，整合设备、饮食和行为数据，以实现个人化介入和可扩展的指导服务。第三，应实现采购多元化，考虑区域性生产和策略供应商合作，以减轻贸易措施的影响，并降低关税带来的成本波动风险。

本报告对本报告中使用的数据来源、分析框架、主要和次要调查方法以及品质保证通讯协定进行了透明的调查方法。

本研究采用多面向方法，结合与主要相关人员的对话、二手文献综述和质性分析，以确保获得基于证据的洞见。主要研究包括对兽医、采购和产品经理以及分销合作伙伴进行结构化访谈，以收集关于临床应用、供应链限制和消费行为的实地观点。二级资讯来源包括同行评审的兽医学文献、监管指导文件和公开的企业披露信息，以检验临床和运营方面的声明。在分析过程中，重点在于证据三角验证，以减少对单一资料类型的依赖，并将观察到的趋势置于更广泛的行业趋势背景下进行解读。

这项全面的整合，为相关人员提取了见解，重申了策略重点，并概述了研究、投资和合作倡议的下一步。

本报告的结论整合了对临床、生产、分销和政策领域中相关人员的关键启示。对循证、可扩展的肥胖管理解决方案的持续需求，为涵盖营养管理、监测设备和兽医主导项目的综合产品和服务模式提供了机会。同时，贸易政策变化和供应链波动等外部压力要求企业在采购方面保持灵活性，在定价方面保持透明，并与相关人员进行积极沟通。最永续的方法是将严谨的临床实践与使用者友善的交付方式相结合，从而支持依从性和可衡量的结果。

目录

第一章：序言

第二章：调查方法

• 调查设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查的前提
• 研究限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会映射
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 宠物肥胖管理市场：依年龄组别划分

• 成人版
• 小猫
• 小狗
• 进阶的

第九章 宠物肥胖管理市场：依产品分类

• 装置
• 减肥食品
• 服务
• 补充

第十章：宠物肥胖管理市场：依通路划分

• 在线的
• 宠物专卖店
• 超级市场和大卖场
• 动物医院

第十一章 宠物肥胖管理市场：依地区划分

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十二章 宠物肥胖管理市场：依组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十三章 宠物肥胖管理市场：依国家划分

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十四章：美国宠物肥胖管理市场

第十五章：中国宠物肥胖管理市场

第十六章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Colgate-Palmolive Company
• Diamond Pet Foods, LLC
• Drools Pet Food Pvt. Ltd.
• General Mills, Inc.
• Mars, Incorporated
• Merrick Pet Care Inc.
• Midwestern Pet Foods, Inc.
• Nestle SA
• Rolf C. Hagen, Inc.
• Spectrum Brands Holdings, Inc.
• The JM Smucker Company
• WellPet LLC
• Zoetis Inc.

The Pet Obesity Management Market was valued at USD 9.87 billion in 2025 and is projected to grow to USD 10.53 billion in 2026, with a CAGR of 8.47%, reaching USD 17.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 9.87 billion
Estimated Year [2026]	USD 10.53 billion
Forecast Year [2032]	USD 17.45 billion
CAGR (%)	8.47%

Comprehensive introduction to pet obesity management that frames the market dynamics, stakeholder priorities, and the emerging drivers shaping future strategies

Pet obesity management has moved from a peripheral welfare concern to a central pillar of preventive health strategy for companion animals. Increasing veterinary recognition of obesity as a contributor to chronic disease, combined with rising pet ownership and greater humanization of animals, has catalyzed demand for interventions that integrate diagnostics, nutrition, behavior modification, and monitoring technologies. Stakeholders across veterinary practice, specialty manufacturing, retail distribution, and pet care services are revising priorities to address weight-related conditions while balancing owner expectations for convenience, cost, and humane approaches.

In this context, the landscape is shaped by converging trends in consumer awareness, clinical guidelines, and product innovation. Pet owners are more informed about nutrition and activity needs than in prior decades, and they increasingly seek evidence-backed solutions that fit their lifestyles. At the same time, veterinary clinicians are adopting standardized body condition scoring and integrating weight management into routine visits, which elevates the role of clinical recommendations in purchase decisions. Manufacturers and service providers are responding with products and programs that emphasize measurable outcomes, ease of use, and subscription-based continuity. Consequently, organizations that can articulate clinical efficacy, demonstrate behavioral adherence, and align distribution channels with owner preferences will shape the next phase of market development.

Transitioning from diagnosis to sustained weight management requires cross-functional collaboration and data-driven decisions. This report's introduction frames those dynamics, identifies the primary stakeholder motivations, and establishes the analytical lens used throughout the subsequent sections to evaluate strategic options and implementation pathways.

Analysis of transformative shifts revamping pet obesity management including technology adoption, consumer behavior, and the evolving role of veterinary care and retail channels

The past several years have seen transformative shifts that are fundamentally redefining how pet obesity is prevented, diagnosed, and managed. Advances in wearable activity monitors and connected feeding devices have introduced continuous behavioral data that enables personalized plans and remote monitoring. Parallel shifts in retail and veterinary service models, such as subscription offerings and telehealth consultations, have increased accessibility and adherence to multi-month weight management programs. These technological and service innovations are supported by a cultural trend toward treating pets as family members, which elevates owner willingness to invest in prevention and long-term care.

Moreover, clinical practice is evolving: standardized assessment tools and growing evidence linking obesity management to improved comorbidity outcomes have strengthened the veterinary community's role as an influencer of owner behavior. As a result, product development has shifted toward integrated solutions that combine dietary formulations, monitoring devices, and human-centered coaching to drive sustained weight loss and maintenance. At the same time, regulatory attention on product labeling and claims has grown, prompting manufacturers to align evidence-generation plans with compliance expectations.

These shifts carry strategic implications for stakeholders who must reconcile speed-to-market with the need for clinical validation. Organizations that adopt interoperable data models, form alliances with veterinary networks, and create scalable adherence programs will benefit from higher retention and more defensible value propositions. Consequently, the landscape favors multidisciplinary approaches that integrate nutrition science, digital health, and behavioral design into coherent offerings.

Assessment of the cumulative impact of United States tariffs in 2025 on pet obesity management supply chains, procurement costs, and cross-border product flows

The introduction of expanded tariff measures in the United States in 2025 has produced cascading effects for suppliers, manufacturers, distributors, and end users in the pet obesity management ecosystem. Tariffs on imported raw materials, specialized components for monitoring devices, and certain finished nutritional products have increased landed costs and altered sourcing calculus. In response, procurement teams have initiated supplier diversification, nearshoring, and cost-pass-through strategies, which in turn influence product pricing, promotional tactics, and channel economics. These shifts are particularly pronounced for companies reliant on high-precision sensors and proprietary components that have limited domestic alternatives.

Consequently, distributors and retailers are reevaluating inventory strategies and contract terms, with some extending lead times to mitigate cost volatility and others negotiating volume-based rebates to stabilize margins. Veterinary clinics that historically recommended branded dietary products face more complex conversations with clients as price sensitivity grows and alternative domestic formulations become more prevalent. In parallel, smaller manufacturers that previously competed on price are emphasizing localized manufacturing and vertically integrated supply to retain resilience against tariff-induced disruptions.

Looking ahead, organizations will need to balance short-term tactical responses with strategic investments in supply chain transparency and supplier relationships. Scenarios that include continued trade frictions will favor firms that can demonstrate flexible sourcing, cost containment without compromising clinical efficacy, and clear communication with practitioners and pet owners about the rationale for product choices and pricing. In this evolving environment, proactive supply chain risk management and adaptive commercial models will be essential to preserve both access and quality of obesity management solutions.

Strategic insights derived from segmentation across age cohorts, animal types, product categories, and distribution channels to guide targeted product and service planning

Understanding performance at a granular level requires attention to the ways that age, species, product type, and distribution pathways interact to shape demand and outcomes. Age cohorts influence both prevalence and treatment pathways: adult animals often require ongoing maintenance strategies, kittens and puppies benefit from early-life nutritional interventions and behavior training, and senior animals require adjusted formulations and monitoring to manage comorbidities. Animal type is also decisive; cats and dogs exhibit distinct metabolic and behavioral profiles, and within these groups further heterogeneity arises. Cats are frequently segmented by breed type such as domestic shorthair and purebred, which can correlate with activity levels and metabolic predispositions. Dogs are commonly evaluated by breed size, where large breed, medium breed, and small breed categories influence caloric needs, exercise prescriptions, and product portioning.

Product portfolios typically span devices, dietary food, services, and supplements, with each category playing a complementary role in comprehensive management. Devices that enable remote tracking and smart feeding create data streams that reinforce dietary and service interventions. Dietary food formulations are tailored to life stage and physiologic considerations and often anchor clinical recommendations. Services that encompass behavioral coaching, veterinary consultations, and structured programs foster adherence, while supplements provide adjunctive metabolic or appetite-regulating support. Distribution channels further modulate access and consumer experience. Online platforms offer convenience and subscription models that support long-term compliance, pet specialty stores deliver curated experiences and in-person advice, supermarkets and hypermarkets provide broad access and price-driven options, and veterinary clinics serve as an evidence-based recommendation source and point of program initiation.

When integrated, these segmentation dimensions reveal distinct pathways for product positioning and channel strategies. For example, a small-breed dog owner seeking convenience may respond strongly to an online, subscription-based dietary and device bundle, whereas owners of senior large-breed dogs may prioritize veterinary-led programs with prescription nutrition and in-clinic monitoring. Segment-specific strategies that align product attributes with the unique needs of each age group, animal type, and distribution preference will underpin effective commercialization and clinical adoption.

Regional dynamics and comparative insights across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence product development, distribution and policy responses

Regional dynamics exert a powerful influence on product design, distribution strategy, regulatory compliance, and consumer expectations. In the Americas, a mature veterinary channel and high rates of pet humanization drive demand for clinically validated solutions, subscription services, and premium dietary products. Consumers in this region typically expect integrated offerings that combine nutrition, monitoring, and professional support, and distributors often partner closely with clinics to create referral pathways and compliance programs.

Across Europe, the Middle East & Africa, regulatory frameworks and fragmented retail ecosystems create heterogeneous opportunities. Many European markets emphasize safety and evidence for clinical claims, while retail channels vary between strong specialty retail networks and consolidated supermarket players. The Middle East and Africa present pockets of high-growth urban demand alongside infrastructural constraints that favor durable, easily distributed products. In contrast, the Asia-Pacific region exhibits rapid adoption of digital retail and telehealth models, with a wide range of consumer segments from highly urbanized, premium-oriented owners to value-conscious buyers in emerging markets. Supply chain considerations, cultural attitudes toward pet care, and regulatory approaches differ substantially across these regions, shaping the relative appeal of imported versus locally produced products.

Therefore, regional strategies should reflect local clinical practice patterns, regulatory expectations for product claims, and preferred distribution models. Market entry and expansion planning must account for these differences by aligning evidence generation, packaging and labeling decisions, and channel partnerships to regional norms while preserving core brand promises and clinical integrity.

Competitive landscape overview highlighting leading companies' strategic priorities, partnership behaviors, innovation themes, and criteria for market differentiation

Competitive positioning in pet obesity management centers on the ability to combine clinical credibility with scalable distribution and differentiated customer experiences. Leading companies approach this challenge through multidisciplinary investments in R&D, partnerships with veterinary networks, and pilots that validate integrated offerings in real-world settings. Common strategic priorities include building evidence bases for product claims, developing interoperable device and data platforms, and creating service models that foster long-term adherence. Some organizations emphasize premium nutritional science and clinical trial data to support veterinarian endorsements, while others focus on digital engagement and subscription economics to drive recurring revenue.

Partnership behavior is another distinguishing feature; companies that form alliances with feed manufacturers, device producers, and veterinary service providers can accelerate route-to-market and create bundled value propositions. Innovation themes often cluster around personalization, interoperability, and behavioral nudges-solutions that use activity and feeding data to generate actionable insights and automated adjustments. At the same time, differentiation increasingly rests on supply chain resilience and the ability to sustain margin in the face of commodity cost swings and trade disruptions.

For stakeholders evaluating competitive moves, success depends on demonstrating measurable outcomes, integrating across the product-service continuum, and tailoring go-to-market approaches to priority segments and regions. Organizations that can balance clinical leadership with pragmatic distribution and pricing strategies will secure stronger practitioner endorsement and higher owner retention.

Actionable recommendations for industry leaders to capitalize on growth opportunities, mitigate risks from trade shifts, and accelerate responsible obesity management programs

Industry leaders should pursue a set of pragmatic actions that align clinical credibility with commercial scalability. First, prioritize evidence generation through pragmatic clinical studies and real-world outcome monitoring to substantiate product claims and strengthen veterinary recommendations. Second, develop interoperable digital platforms that aggregate device, dietary, and behavioral data to enable personalized interventions and scalable coaching services. Third, diversify sourcing and consider regional manufacturing or strategic supplier partnerships to mitigate the effects of trade measures and reduce exposure to tariff-driven cost volatility.

Additionally, refine channel strategies to meet distinct segment needs by matching product bundles to owner profiles and distribution preferences. For owners seeking convenience, combine subscription dietary offerings with smart feeders and virtual coaching. For clinical cases, create clear referral pathways from veterinary clinics supported by training and co-branded educational materials. Invest in training for veterinary professionals so that practitioners can confidently prescribe and monitor multi-component programs, thereby increasing adherence and long-term outcomes. Finally, adopt transparent pricing and communication strategies that explain product choices and any cost implications associated with supply chain adjustments.

Taken together, these actions help organizations maintain clinical integrity, protect margin, and deliver consumer-centric solutions that improve animal welfare. Executives should treat these recommendations as interdependent: investments in evidence and digital capabilities will amplify channel effectiveness and support resilience against external trade and cost pressures.

Transparent research methodology describing data sources, analytical frameworks, primary and secondary research approaches, and quality assurance protocols used in this report

This research employed a multi-method approach combining primary stakeholder engagement, secondary literature review, and qualitative synthesis to ensure robust and defensible insights. Primary inquiries included structured interviews with practicing veterinarians, procurement and product leaders, and distribution partners to capture frontline perspectives on clinical adoption, supply chain constraints, and consumer behavior. Secondary sources encompassed peer-reviewed veterinary literature, regulatory guidance documents, and public corporate disclosures to validate clinical and operational assertions. The analysis prioritized triangulation of evidence to reduce reliance on any single data type and to contextualize observed trends within broader industry dynamics.

Analytical frameworks used in this study integrated segmentation analysis, scenario planning around trade and supply chain disruptions, and a capabilities assessment for innovation readiness. Quality assurance protocols included cross-validation of interview findings, verification of regulatory interpretations against primary sources, and a review cycle with external subject-matter experts. Limitations were acknowledged where primary data density varied across regions or segments, and sensitivity analyses were used to test assumptions in the scenarios. Wherever possible, findings were presented in a manner that emphasizes observable behaviors and strategic implications rather than speculative numerical projections.

This transparent methodology ensures that conclusions and recommendations are grounded in real-world practice and supported by a diversity of evidence, offering decision-makers a reliable foundation for strategy and investment planning.

Concluding synthesis that distills implications for stakeholders, reiterates strategic priorities, and frames next steps for research, investment and collaborative initiatives

The conclusion synthesizes the report's core implications for stakeholders across clinical, manufacturing, distribution, and policy domains. Persistent demand for evidence-based, scalable obesity management solutions is creating opportunities for integrated product-service models that combine nutrition, monitoring devices, and veterinary-led programs. At the same time, external pressures such as trade policy changes and shifting supply chain dynamics require organizations to be nimble in sourcing, transparent in pricing, and proactive in stakeholder communication. The most sustainable approaches blend clinical rigor with consumer-friendly delivery mechanisms that support adherence and measurable outcomes.

Strategically, organizations should treat obesity management as a long-term care category that benefits from subscription models, cross-channel partnerships, and continuous outcome measurement. Tactical actions that align product design with regional regulatory expectations, segment-specific needs, and supply chain realities will determine competitive advantage. Finally, collaborative initiatives that involve veterinarians, manufacturers, and retailers hold promise for accelerating adoption and improving pet health outcomes at scale.

In closing, the evolving interplay of clinical science, digital tools, and distribution innovation presents a constructive pathway to improve animal welfare while creating commercially viable solutions. The organizations that invest in evidence, cross-functional integration, and supply chain resilience will be best positioned to lead this next chapter of pet obesity management.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pet Obesity Management Market, by Age Group

• 8.1. Adult
• 8.2. Kitten
• 8.3. Puppy
• 8.4. Senior

9. Pet Obesity Management Market, by Product

• 9.1. Device
• 9.2. Dietary Food
• 9.3. Service
• 9.4. Supplement

10. Pet Obesity Management Market, by Distribution Channel

• 10.1. Online
• 10.2. Pet Specialty Stores
• 10.3. Supermarkets & Hypermarkets
• 10.4. Veterinary Clinics

11. Pet Obesity Management Market, by Region

• 11.1. Americas
  • 11.1.1. North America
  • 11.1.2. Latin America
• 11.2. Europe, Middle East & Africa
  • 11.2.1. Europe
  • 11.2.2. Middle East
  • 11.2.3. Africa
• 11.3. Asia-Pacific

12. Pet Obesity Management Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Pet Obesity Management Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. United States Pet Obesity Management Market

15. China Pet Obesity Management Market

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025
• 16.5. Colgate-Palmolive Company
• 16.6. Diamond Pet Foods, LLC
• 16.7. Drools Pet Food Pvt. Ltd.
• 16.8. General Mills, Inc.
• 16.9. Mars, Incorporated
• 16.10. Merrick Pet Care Inc.
• 16.11. Midwestern Pet Foods, Inc.
• 16.12. Nestle S.A.
• 16.13. Rolf C. Hagen, Inc.
• 16.14. Spectrum Brands Holdings, Inc.
• 16.15. The J. M. Smucker Company
• 16.16. WellPet LLC
• 16.17. Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL PET OBESITY MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL PET OBESITY MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 11. CHINA PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY KITTEN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY KITTEN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY KITTEN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PUPPY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PUPPY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PUPPY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SENIOR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SENIOR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SENIOR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DEVICE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DEVICE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DIETARY FOOD, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DIETARY FOOD, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DIETARY FOOD, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SERVICE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SERVICE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPPLEMENT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPPLEMENT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPPLEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 42. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 43. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 44. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 45. AMERICAS PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 46. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 48. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 49. NORTH AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 50. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 52. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 53. LATIN AMERICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 58. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 59. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 60. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 61. EUROPE PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 62. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 64. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 65. MIDDLE EAST PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 66. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 67. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 68. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 69. AFRICA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 70. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 71. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 72. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 73. ASIA-PACIFIC PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 75. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 76. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 77. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 78. ASEAN PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 79. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 80. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 81. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 82. GCC PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 83. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 84. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 85. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 86. EUROPEAN UNION PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 87. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 88. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 89. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 90. BRICS PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 91. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 92. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 93. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 94. G7 PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 95. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 96. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 97. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 98. NATO PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 99. GLOBAL PET OBESITY MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 101. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 102. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 103. UNITED STATES PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 104. CHINA PET OBESITY MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 105. CHINA PET OBESITY MANAGEMENT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 106. CHINA PET OBESITY MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 107. CHINA PET OBESITY MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)